论文部分内容阅读
目的:探究布地奈德与孟鲁司特钠治疗支气管哮喘的治疗效果。方法:选取在我院治疗支气管哮喘患者80例作为研究对象,根据不同治疗方法分为两组,对照组40例,观察组40例。对照组给予孟鲁司特钠治疗,观察组则在对照组的用药基础上加入布地奈德治疗,比较两组治疗后的临床疗效及出院后的复发情况。结果:对照组的总有效率和复发率分别为67.50%、32.50%,观察组的总有效率和复发率分别为87.50%、12.50%,观察组的总有效率明显高于对照组,其复发率低于对照组,且P<0.05,差异具有统计学意义。结论:布地奈德与孟鲁司特钠联合治疗支气管哮喘疗效更佳、复发率低,值得临床推广。
Objective: To investigate the therapeutic effect of budesonide and montelukast sodium on bronchial asthma. Methods: Eighty patients with bronchial asthma in our hospital were selected as research objects. According to different treatment methods, they were divided into two groups: control group (40 cases) and observation group (40 cases). The control group was given montelukast sodium. The observation group was treated with budesonide on the basis of the control group. The clinical efficacy and the recurrence after discharge were compared between the two groups. Results: The total effective rate and recurrence rate in the control group were 67.50% and 32.50% respectively. The total effective rate and recurrence rate in the observation group were 87.50% and 12.50% respectively. The total effective rate in the observation group was significantly higher than that in the control group The rate was lower than the control group, and P <0.05, the difference was statistically significant. Conclusion: The combination of budesonide and montelukast sodium in bronchial asthma has better curative effect and lower recurrence rate, which deserves clinical promotion.